Albireo Pharma logo
Albireo Pharma ALBO

Quarterly report 2022-Q3
added 11-08-2022

report update icon

Albireo Pharma Depreciation & Amortization 2011-2026 | ALBO

Annual Depreciation & Amortization Albireo Pharma

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
274 K 192 K 127 K 45 K 35 K 14 K 15 K 603 K 641 K 725 K 938 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
938 K 14 K 328 K

Quarterly Depreciation & Amortization Albireo Pharma

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 322 K 198 K 114 K - 167 K 75 K 37 K - 119 K 77 K 39 K - 89 K 50 K 11 K - 33 K 22 K 53 K - 23 K 13 K 5 K - 11 K 7 K 4 K 30 K 211 K 164 K - 102 K 462 K 310 K 102 K 156 K 484 K 326 K 156 K 167 K 555 K 382 K 167 K 194 K 732 K 502 K 194 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
732 K 4 K 172 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer Depreciation & Amortization Price % 24h Market Cap Country
Rezolute Rezolute
RZLT
31 K $ 3.37 5.82 % $ 256 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
27 K - 1052.0 % $ 415 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
58 K - 5.93 % $ 314 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
18 K - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
2.49 M - 0.23 % $ 488 M usaUSA
I-Mab I-Mab
IMAB
23.9 M - - $ 866 M chinaChina
Aileron Therapeutics Aileron Therapeutics
ALRN
63 K - 10.36 % $ 9.8 M usaUSA
Cabaletta Bio Cabaletta Bio
CABA
1.65 M $ 2.85 2.34 % $ 286 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.51 M - - $ 26.5 M usaUSA
Sana Biotechnology Sana Biotechnology
SANA
12.8 M $ 3.13 0.97 % $ 793 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
100 K - -10.17 % $ 12.2 K usaUSA
Aptinyx Aptinyx
APTX
122 K - -39.0 % $ 4.57 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
31.7 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
7 K - 4.01 % $ 150 M canadaCanada
Equillium Equillium
EQ
116 K $ 2.11 2.43 % $ 121 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
3.65 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
66 K - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
369 K - -9.65 % $ 45.9 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
162 K - - $ 7.46 M israelIsrael
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
7.55 M $ 1.34 0.75 % $ 342 M britainBritain
Atreca Atreca
BCEL
5.46 M - -11.76 % $ 5.79 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
142 M - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
28 M - - $ 546 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
140 K - -4.8 % $ 255 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
259 K - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
3.14 M - - $ 3.74 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
744 K - - $ 1.01 B usaUSA
Avid Bioservices Avid Bioservices
CDMO
11.1 M - - $ 789 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
19.5 M $ 48.18 2.32 % $ 4.33 B schweizSchweiz
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
363 K $ 4.49 -0.99 % $ 860 M canadaCanada
AIkido Pharma AIkido Pharma
AIKI
105 K - 1.93 % $ 17.4 M usaUSA
Allakos Allakos
ALLK
6.14 M - - $ 28.6 M usaUSA
Seer Seer
SEER
5.6 M $ 1.72 -0.29 % $ 110 M usaUSA
Brickell Biotech Brickell Biotech
BBI
41 K - -5.38 % $ 6.06 M usaUSA
Eli Lilly and Company Eli Lilly and Company
LLY
2 B $ 905.44 -1.19 % $ 812 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
363 K - 3.16 % $ 1.9 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
300 K - -10.95 % $ 876 K usaUSA